Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02355080 · ClinicalTrials.gov registry record · Phase 2
A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results
A Phase 2 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 134
- Enrollment target
NCT02355080 is a Phase 2 study that has completed, run by Columbia University. The registered enrollment target is 134 participants.
The verdict
NCT02355080, a Phase 2 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 134 participants
- Enrollment target
Study Summary
This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a HIV and hepatitis C (HCV) testing study. The purpose of this study is to test the efficacy of two HIV/HCV testing strategies on increasing receipt of test results: (1) on-site bundled rapid HIV/HCV testing (i.e., joint offer of HIV and HCV at the point of encounter), and (2) standard of care for HIV and HCV testing.
Interventions
- BEHAVIORAL On-site bundled rapid HIV/HCV testing
- BEHAVIORAL Standard of care (SOC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02355080
The ClinicalTrials.gov registry entry for NCT02355080 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which On-site bundled rapid HIV/HCV testing is the first listed.
NCT02355080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02355080 about?
NCT02355080 is a clinical study titled "A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results". This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a HIV and hepatitis C (HCV) testing study. The purpose of this study is to test the efficacy of two HIV/HCV testing strategies on increasing receipt of test results: (1) ...
What is the current status of trial NCT02355080?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 134 participants. The study started on 2016-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02355080?
The interventions under investigation include: On-site bundled rapid HIV/HCV testing (BEHAVIORAL), Standard of care (SOC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02355080?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.